MASIMO CORP

MASIMO CORPMASIEarnings & Financial Report

Nasdaq · Health Care · Electromedical & Electrotherapeutic Apparatus

Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.

Revenue

$600.7M

Gross Profit

$244.7M

Operating Profit

$-359.1M

Net Profit

$-349.6M

Gross Margin

40.7%

Operating Margin

-59.8%

Net Margin

-58.2%

YoY Growth

9.4%

EPS

$-6.54

MASIMO CORP Q4 FY2024 Financial Summary

MASIMO CORP reported revenue of $600.7M (up 9.4% YoY) for Q4 FY2024, with a net profit of $-349.6M (down 1131.3% YoY) (-58.2% margin). Cost of goods sold was $356.0M, operating expenses totaled $603.8M.

Key Financial Metrics

Total Revenue$600.7M
Net Profit$-349.6M
Gross Margin40.7%
Operating Margin-59.8%
Report PeriodQ4 FY2024

Revenue Breakdown

MASIMO CORP Q4 FY2024 revenue of $600.7M breaks down across 2 segments, led by Health Care Segment at $368.4M (61.3% of total).

SegmentRevenue% of Total
Health Care Segment$368.4M61.3%
Non Healthcare$232.3M38.7%

MASIMO CORP Revenue by Segment — Quarterly Trend

MASIMO CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Health Care Segment and Non Healthcare) has evolved quarter over quarter.

SegmentQ3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Health Care Segment$371.2M$370.3M$368.4M
Non Healthcare$232.3M

MASIMO CORP Annual Revenue by Year

MASIMO CORP annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.1B).

YearAnnual Revenue
2024$2.1B
2023$2.0B
2022$2.0B
2021$1.2B

MASIMO CORP Quarterly Revenue & Net Profit History

MASIMO CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2025$371.5M-26.4%$-100.4M-27.0%
Q2 FY2025$370.9M-25.3%$51.3M13.8%
Q1 FY2025$372.0M-24.5%$-170.7M-45.9%
Q4 FY2024$600.7M+9.4%$-349.6M-58.2%
Q3 FY2024$504.6M+5.4%$9.8M1.9%
Q2 FY2024$496.3M+9.0%$16.0M3.2%
Q1 FY2024$492.8M-12.8%$18.9M3.8%
Q4 FY2023$548.9M-11.0%$33.9M6.2%

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$548.9M$492.8M$496.3M$504.6M$600.7M$372.0M$370.9M$371.5M
YoY Growth-11.0%-12.8%9.0%5.4%9.4%-24.5%-25.3%-26.4%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$3.04B$2.96B$2.89B$3.09B$2.63B$2.29B$2.40B$1.82B
Liabilities$1.68B$1.59B$1.53B$1.62B$1.57B$1.35B$1.36B$1.01B
Equity$1.36B$1.37B$1.37B$1.46B$1.05B$946.4M$1.04B$810.0M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$77.1M$45.8M$74.5M$25.6M$50.5M$31.1M$69.4M$56.8M